Back
AN2 Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
ANTX
AN2 Therapeutics, Inc.
Last Price:
$1.14
Seasonality Move:
15.13%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and ANTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
AN2 Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Sell |
| 20-day SMA: | 1.12 | Buy |
| 50-day SMA: | 1.15 | Sell |
| 200-day SMA: | 1.19 | Sell |
| 8-day EMA: | 1.14 | Buy |
| 20-day EMA: | 1.13 | Buy |
| 50-day EMA: | 1.15 | Sell |
| 200-day EMA: | 1.33 | Sell |
AN2 Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 51 | Buy |
| Chaikin Money Flow: | 11993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.07 - 1.15) | Buy |
| Bollinger Bands (100): | (1.1 - 1.26) | Sell |
AN2 Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for AN2 Therapeutics, Inc. Stock
Is AN2 Therapeutics, Inc. Stock a Buy?
-
AN2 Therapeutics, Inc. share price is 1.14 while ANTX 8-day simple moving average is 1.15, which is a Sell signal.
-
The stock price of ANTX is 1.14 while AN2 Therapeutics, Inc. 20-day SMA is 1.12, which makes it a Buy.
-
AN2 Therapeutics, Inc. 50-day simple moving average is 1.15 while ANTX share price is 1.14, making it a Sell technically.
-
ANTX stock price is 1.14 and AN2 Therapeutics, Inc. 200-day simple moving average is 1.19, creating a Sell signal.
ANTX Technical Analysis vs Fundamental Analysis
Sell
34
AN2 Therapeutics, Inc. (ANTX)
is a Sell
Is AN2 Therapeutics, Inc. a Buy or a Sell?
-
AN2 Therapeutics, Inc. stock is rated a SellThe current AN2 Therapeutics, Inc. [ANTX] share price is $1.14. The Score for ANTX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
AN2 Therapeutics, Inc. Stock Info
Market Cap:
31.2M
Price in USD:
1.14
Share Volume:
14.3K
AN2 Therapeutics, Inc. 52-Week Range
52-Week High:
1.55
52-Week Low:
1.01
Sell
34
AN2 Therapeutics, Inc. (ANTX)
is a Sell
AN2 Therapeutics, Inc. Share Price Forecast
-
What is the AN2 Therapeutics, Inc. stock price today?The AN2 Therapeutics, Inc. stock price is 1.14 USD today.
-
Will ANTX stock go up or go down?AN2 Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is AN2 Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, AN2 Therapeutics, Inc. is overvalued.
Is AN2 Therapeutics, Inc. Stock a Buy?
-
AN2 Therapeutics, Inc. share price is 1.14 while ANTX 8-day exponential moving average is 1.14, which is a Buy signal.
-
The stock price of ANTX is 1.14 while AN2 Therapeutics, Inc. 20-day EMA is 1.13, which makes it a Buy.
-
AN2 Therapeutics, Inc. 50-day exponential moving average is 1.15 while ANTX share price is 1.14, making it a Sell technically.
-
ANTX stock price is 1.14 and AN2 Therapeutics, Inc. 200-day simple moving average is 1.33, creating a Sell signal.
Fundamental Analysis of AN2 Therapeutics, Inc.
Is AN2 Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.21 per share.
Technical Analysis of AN2 Therapeutics, Inc.
Should I short AN2 Therapeutics, Inc. stock?
-
ANTX Moving Average Covergence Divergence (MACD) indicator is -0, suggesting AN2 Therapeutics, Inc. is a Sell
-
AN2 Therapeutics, Inc. Relative Strength Index (RSI) is 51, which suggest AN2 Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for AN2 Therapeutics, Inc. is (1.07 - 1.15), which suggest AN2 Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for AN2 Therapeutics, Inc. is (1.1 - 1.26), which suggest AN2 Therapeutics, Inc. is a Sell
* AN2 Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.